FDA Investigator Jeannie Pradyanata
Jeannie Pradyanata has inspections in 1 countries as of 04 Mar 2024. Jeannie Pradyanata has collaborated with a combined 2896 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
200
Last Inspection Date:
04 Mar 2024
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Abby M Miller,
Albert C Cheng,
Alexandra B Pitkin,
Alice A Blair,
Ana Djurdjevic,
Ana M Pietsch,
Anthony E Guzman,
Arnold C Shih,
Aron T Kifle,
Avery J Dennis,
Benigno B Devera,
Brandon R Boone,
Breena L D'ambrogi,
Brian P Putz,
Brian Ravitch,
Bruce R Burrell,
Bryan A Galvez,
Burnsb,
Bush,
Camille Bennett Hoffman,
Carr Sharpe,
Cassandra L Abellard,
Cathleen A Carr Sharpe,
Cathryn M Groehnert,
Celena Ngo,
Christine M Rivera,
Christopher J Stannard,
Christopher M Lock,
Cynthia L Medlin,
Daniel J Simonsen,
Danielle M Didonna,
Darrin E Davis,
David A Quale,
David C Thomas,
Davis,
Dawn E Barkans,
Deborah W Hsu,
Debra J Fracassa,
Denise H Howell,
Dennis G Poertner,
Desiree C Iya,
Djamila Harouaka,
Edna J Hidalgo,
Eileen T Dupont,
Elizabeth M Dahl,
Emal Wahab,
Erik D Sandvig,
Fe Q Reyes,
Fidel Carrillo,
Francisco,
Geoffrey M Leist,
Geraldine M Peregrin,
Gerard Pde Leon,
Gordon Chu,
Gulshan R Anand,
Hai T Truong,
Henry E Carrillo,
Herminio C Francisco,
Hoover,
Ian J Thomson,
Jake T Lane,
James A Barreto,
James P Stallings,
Jason T Tuuao,
Jeff M Uriarte,
Jeffrey D Sloan,
Jeffrey N Gerdes,
Jeffrey W Shrifter, DPM,
Jennifer Crumb,
Jennifer M Heitz,
Jessica J Lee,
Jessica L Andrade,
Jinnie Kokiatkulkij,
John A Liu,
John C Su,
John P Jorgensen,
John R Myung,
Jonathan R Ormond,
Jonathan T Little,
Joseph Brady,
Joseph C Francisco,
Joseph C Yen,
Joseph H Lam,
Judy C Nepsa,
Kai Wang,
Karen L Bauer,
Katherine P Chan,
Kelvin X Sanders,
Kevin Lee,
Kevin T Gerrity,
Khang K Pham,
Kimberly F Mills,
Kimberly M Lichter,
Kristina M Phelps,
Lakecha N Lewis,
Lesley A Swanson,
Lestine C Webb,
Ligia M Sanders,
Lilly O Barton,
Lin Liu,
Linda Thai,
Ling Yul Liu,
Lopez,
Lorraine N Williams,
Lourdes M Countee,
Lucila B Nwatu,
Marco A Solorio,
Margo Cl Jones,
Maria C Fermin,
Mark C Saale,
Mark Gray,
Mark I Nakano,
Matthew C Kristof,
Matthew Lam,
Melody M Ragasa Leong,
Michael D Garcia,
Michael S Call,
Michele R Douglas,
Misty L Treece,
Misty L Wallace,
Nancy E Byerly,
Natalie J Ayoub,
Nianna C Burns,
Nicholas J Lahey,
Nympha V Florendo,
Othello G Capangpangan,
Pamela Y Lee,
Patricia F Alberico,
Patrick R Dimapindan,
Phal K Chhun,
Phillip J Dugger,
Phillip J Sample,
Richard W Tubb,
Riley C Graham,
Robert C Hoover,
Robert D Ogan,
Rocco C Black,
Ronald E Gill,
Ronald P Boyce,
Sabrina J Dethloff,
Sandersk,
Sandra K Wangen,
Sara Jdent Acosta,
Sarah R Gal,
Savini,
Sean P Desbrow,
Shaquenta Y Perkins,
Shelagh D Schopen,
Sherry G Gonzalez,
Sorana Black,
Sparky L Bartee,
State Agency,
Steve P Yost,
Steven B Chiu,
Sundy V Sedwick,
Sundy Ven,
Susanna N Choi,
Tamara L Alexander,
Tammy Vasquez Hancock,
Tanya E Malais,
Tawny L Colling,
Terrance P Nguyen,
Thanh B Tran,
Thanh M Andrews,
Thao T Kwan,
Thomas C Mclean, CFS,
Tony J Wu,
Travell D Sawyer,
Trushani T Desai,
Wayne L Jefferson,
William J Park,
Willis L Hicks,
Xavier M Rios,
Yolanda D Mitchell Lee,
Yvette Mlacour Davis,
Zachary A Bogorad
Jeannie Pradyanata's Documents
Publish Date | Document Type | Title |
---|---|---|
September, 2017 | EIR | Azile Inc. - EIR, 2017-09-06 |
September, 2017 | FDA 483 | Azile Inc. - Form 483, 2017-09-06 |
February, 2018 | EIR | United Exchange Corp. - EIR, 2018-02-14 |
February, 2018 | FDA 483 | United Exchange Corp. - Form 483, 2018-02-14 |
April, 2019 | FDA 483 | Cconma, Inc. - Form 483, 2019-04-25 |
February, 2022 | FDA 483 | Cconma, Inc. - Form 483, 2022-02-08 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more